4-(苯基氨基)丁酸 | 87962-87-6

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 中文名称: 4-(苯基氨基)丁酸
• 英文名称: 4-(phenylamino)butanoic acid
• 英文别名: 4-Anilinobutanoic acid
• CAS: 87962-87-6
• 化学式: C₁₀H₁₃NO₂
• mdl: MFCD09931659
• 分子量: 179.219
• InChiKey: WHXFWSFZCBNZLK-UHFFFAOYSA-N

物化性质

• 沸点：
  384.9±25.0 °C(Predicted)
• 密度：
  1.171±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.4
• 重原子数：
  13
• 可旋转键数：
  5
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.3
• 拓扑面积：
  49.3
• 氢给体数：
  2
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  4-(苯基氨基)丁酸 在 盐酸 、 potassium chloride 作用下， 生成 1-苯基-2-吡咯烷酮
  参考文献：
  名称：

  Abdallah, Jassim M.; Moodie, Roy B., Journal of the Chemical Society. Perkin transactions II, 1983, p. 1243 - 1250

  摘要：

  DOI：
• 作为产物：
  描述：

  1-苯基-2-吡咯烷酮 在 盐酸 作用下， 生成 4-(苯基氨基)丁酸
  参考文献：
  名称：

  Abdallah, Jassim M.; Moodie, Roy B., Journal of the Chemical Society. Perkin transactions II, 1983, p. 1243 - 1250

  摘要：

  DOI：

文献信息

• Palladium-catalyzed coupling reaction of amino acids (esters) with aryl bromides and chlorides
  作者：Fangfang Ma、Xiaomin Xie、Lina Ding、Jinsheng Gao、Zhaoguo Zhang

  DOI：10.1016/j.tet.2011.09.109

  日期：2011.12

  showed high efficiency for the coupling reactions of amino acids and inactive aryl halides to give N-aryl amino acids. Under the catalytic conditions, not only α-amino acids, but also β-, γ-, and δ-amino acids have been coupled with aryl chlorides in moderate to high yields; in the case of optically pure β-amino acids as substrates, the optical purities of the coupling products retained.

  庞大且富电子的MOP型配体和Pd（dba）2组合对氨基酸与非活性芳基卤化物的偶合反应显示出N-芳基氨基酸的高效反应。在催化条件下，不仅α-氨基酸，而且β-，γ-和δ-氨基酸都以中等至高收率与芳基氯偶合。在光学纯的β-氨基酸作为底物的情况下，保留了偶联产物的光学纯度。
• Room temperature N-arylation of amino acids and peptides using copper(<scp>i</scp>) and β-diketone
  作者：Krishna K. Sharma、Swagat Sharma、Anurag Kudwal、Rahul Jain

  DOI：10.1039/c5ob00288e

  日期：——

  A mild and efficient method for the N-arylation of zwitterionic amino acids, amino acid esters and peptides is described. The procedure provides the first room temperature synthesis of N-arylated amino acids and peptides using CuI as a catalyst, diketone as a ligand, and aryl iodides as coupling partners. The method is equally applicable for using relatively inexpensive aryl bromides as coupling partners

  描述了一种用于两性离子氨基酸，氨基酸酯和肽的N-芳基化的温和且有效的方法。该方法提供了第一个室温下使用CuI作为催化剂，二酮作为配体，芳基碘化物作为偶联伴侣的N-芳基化氨基酸和多肽的室温合成方法。该方法同样适用于在80°C下使用相对便宜的芳基溴化物作为偶联伙伴。使用该程序，可以有效地以良好至优异的产率偶联含有反应性官能团的电子和空间上不同的芳基卤化物。
• Novel hydroxyphenylurea dual inhibitor against Acyl-CoA
  作者：Kazuya Nakao、Hitoshi Kubota、Mikiko Yasuhara、Keiko Saito、Toshikazu Suzuki、Hiroshi Ohmizu、Ryo Shimizu

  DOI：10.1016/s0968-0896(00)00303-5

  日期：2001.4

  hydroxyphenylurea derivatives were synthesized and their inhibitory potency evaluated against acyl-CoA: cholesterol acyltransferase (ACAT). Quantitative structure activity relationship analysis revealed that their ACAT inhibitory activities were controlled by the hydrophobicity of the whole molecule. the substitution pattern of urea moiety, and the existence of carboxylic acid. The derivatives with strong

  合成了新型羟基苯基脲衍生物，并评估了其对酰基辅酶A：胆固醇酰基转移酶（ACAT）的抑制能力。定量结构活性关系分析表明，它们的ACAT抑制活性受整个分子的疏水性控制。尿素部分的取代方式，以及羧酸的存在。具有强活性的衍生物抑制了泡沫孔的形成。此外，这些化合物由于其特征性的3-叔丁基-2-羟基-5-甲氧基苯基亚结构而对低密度脂蛋白（LDL）表现出抗氧化作用。基于动脉粥样硬化的发生机理，这种针对ACAT和LDL氧化的羟苯基脲类双重抑制剂有望成为一种有前途的动脉粥样硬化药物。
• Pyrazole compounds and their use as antidiabetes agents
  申请人：Takagi Masaki

  公开号：US20070032529A1

  公开（公告）日：2007-02-08

  The present invention provides a pyrazole compound that has liver glycogen phosphorylase inhibitory activity and is useful as a therapeutic or prophylactic agent for diabetes, the pyrazole compound represented by the following general formula (I): wherein Ring Q represents an aryl or heteroaromatic group, R 1 represents a hydrogen atom, a halogen atom, a C 1-6 alkyl group or a C 1-6 alkoxy group, R 2 represents a halogen atom, a C 1-6 alkyl group, a C 1-6 alkoxy group or an azido group, R 3 represents a halogen atom, a hydroxyl group, a C 1-6 alkyl group, a halo C 1-6 alkyl group, a C 1-6 alkoxy group, an azido group, an amino group, an acylamino group or a C 1-6 alkylsulfonylamino group, R 4 and R 5 are identical with or different from each other and represent a hydrogen atom, a substituted or unsubstituted C 1-6 alkyl group, a C 3-8 cycloalkyl group, a substituted or unsubstituted saturated heterocyclic group, a substituted or unsubstituted aryl group, a C 7-14 aralkyl group, a heteroaromatic group, or the like, or a pharmacologically acceptable salt thereof.

  本发明提供了一种具有肝糖原磷酸化酶抑制活性的吡唑化合物，用作糖尿病的治疗或预防剂，所述吡唑化合物由以下通用式（I）表示：其中环Q代表芳基或杂芳基，R1代表氢原子、卤原子、C1-6烷基或C1-6烷氧基，R2代表卤原子、C1-6烷基、C1-6烷氧基或偶氮基，R3代表卤原子、羟基、C1-6烷基、卤代C1-6烷基、C1-6烷氧基、偶氮基、氨基、酰胺基或C1-6烷基磺酰胺基，R4和R5彼此相同或不同，代表氢原子、取代或未取代的C1-6烷基、取代或未取代的C3-8环烷基、取代或未取代的饱和杂环基、取代或未取代的芳基、C7-14芳基烷基、杂芳基等，或其药理学上可接受的盐。
• 4-Arylamino-benzopyran and related compounds
  申请人：BRISTOL-MYERS SQUIBB COMPANY

  公开号：EP0648758A1

  公开（公告）日：1995-04-19

  Compounds having the formula and pharmaceutically acceptable salts thereof wherein X is alkyl, Y is a single bond, -CH₂-, -C(O)-, -O-, -S- or -N(R⁸)- where R⁸ is hydrogen, alkyl, haloalkyl, aryl, arylalkyl, cycloalkyl or (cycloalkyl)alkyl, and R¹ to R⁷ are as defined herein. These compounds have potassium channel activating activity and are useful, therefore for example, as cardiovascular agents.

  具有以下化学式和药学上可接受的盐的化合物，其中X为烷基，Y为单键，-CH₂-，-C（O）-，-O-，-S-或-N（R⁸）-，其中R⁸为氢，烷基，卤代烷基，芳基，芳基烷基，环烷基或（环烷基）烷基，而R¹到R⁷如本文所定义。这些化合物具有钾通道激活活性，因此可用作心血管药物等用途。